SEC Form 4 · accession 0001104659-19-010154
Crinetics Pharmaceuticals, Inc. · CRNX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owners
Scott M Rocklage
10% Owner
John D Diekman
10% Owner
5AM Partners IV, LLC
10% Owner
5AM Ventures IV, L.P.
10% Owner
5AM Co-Investors IV, L.P.
10% Owner
Andrew J. Schwab
10% Owner
Period of report
Feb 20, 2019
Accepted (ET)
Feb 22, 2019 · 8:06 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001658247
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2,F8 | Feb 20, 2019 | J | 451,200 | $0.00 | D | 2,656,442 | I | See foototes |
| Common StockF4,F8 | Feb 20, 2019 | J | 18,800 | $0.00 | D | 110,683 | I | See foototes |
| Common StockF6 | Feb 20, 2019 | J | 4,700 | $0.00 | A | 4,700 | I | See footnote |
| Common StockF6 | Feb 20, 2019 | J | 4,700 | $0.00 | D | 0 | I | See footnote |
| Common StockF10 | Feb 20, 2019 | J | 940 | $0.00 | A | 940 | I | See footnote |
| Common StockF12 | Feb 20, 2019 | J | 940 | $0.00 | A | 940 | I | See footnote |
| Common StockF14 | Feb 20, 2019 | J | 353 | $0.00 | A | 353 | I | See footnote |
| Common StockF16 | Feb 20, 2019 | J | 587 | $0.00 | A | 940 | I | See footnote |
| Common StockF10 | Feb 20, 2019 | J | 783 | $0.00 | A | 1,723 | I | See footnote |
| Common StockF12 | Feb 20, 2019 | J | 783 | $0.00 | A | 1,723 | I | See footnote |
| Common StockF20 | Feb 20, 2019 | J | 783 | $0.00 | A | 1,723 | I | See footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents a pro-rata in-kind distribution of Common Stock of the Issuer by 5AM Ventures IV, L.P. ("Ventures IV") without consideration to its partners.
- F10These securities are held of record by Schwab Family Trust. Mr. Schwab is a trustee and beneficiary of the Schwab Family Trust and disclaims beneficial ownership of these securities, except to the extent of his proportionate pecuniary interest therein.
- F11Represents the receipt of shares of Common Stock of the Issuer by virtue of the pro-rata in-kind distribution by Partners IV to John D. Diekman and Susan P. Diekman Trustees Diekman Revocable Trust Dtd 6/30/95 ("Diekman Trust").
- F12These securities are held of record by Diekman Trust. Dr. Diekman is a trustee and beneficiary of the Diekman Trust and disclaims beneficial ownership of these securities, except to the extent of his proportionate pecuniary interest therein.
- F13Represents the receipt of shares of Common Stock of the Issuer by virtue of the pro-rata in-kind distribution by Partners IV to Scott M. Rocklage Revocable Trust dated March 2, 1999 as amended February 8, 2008; Trustees: Scott M. Rocklage and Patty B. Rocklage ("Rocklage Trust").
- F14These securities are held of record by Rocklage Trust. Dr. Rocklage is a trustee and beneficiary of the Rocklage Trust and disclaims beneficial ownership of these securities, except to the extent of his proportionate pecuniary interest therein.
- F15Represents the receipt of shares of Common Stock of the Issuer by virtue of the pro-rata in-kind distribution by Partners IV to MADRock II LLC ("MADRock II").
- F16These securities are held of record by MADRock II. Dr. Rocklage is a manager of MADRock II and disclaims beneficial ownership of these securities, except to the extent of his proportionate pecuniary interest therein.
- F17Represents the receipt of shares of Common Stock of the Issuer by virtue of the pro-rata in-kind distribution by Co-Investors IV to the Schwab Family Trust.
- F18Represents the receipt of shares of Common Stock of the Issuer by virtue of the pro-rata in-kind distribution by Co-Investors IV to the Diekman Trust.
- F19Represents the receipt of shares of Common Stock of the Issuer by virtue of the pro-rata in-kind distribution by Co-Investors IV to the Scott M. Rocklage Trust u/d/t/ dated October 22, 2015; Trustees: Scott M. Rocklage and Patty B. Rocklage ("Rocklage Trust II").
- F2These securities are held of record by Ventures IV.
- F20These securities are held of record by the Rocklage Trust II. Dr. Rocklage is a trustee and beneficiary of the Rocklage Trust II and disclaims beneficial ownership of these securities, except to the extent of his proportionate pecuniary interest therein.
- F3Represents a pro-rata in-kind distribution of Common Stock of the Issuer by 5AM Co-Investors IV, L.P. ("Co-Investors IV") without consideration to its partners.
- F4These securities are held of record by Co-Investors IV.
- F5Represents a change in the form of ownership of 5AM Partners IV, LLC ("Partners IV") by virtue of the receipt of shares in the pro-rata in-kind distribution of Common Stock of the Issuer for no consideration by Ventures IV and Co-Investors IV.
- F6These securities are held of record by Partners IV.
- F7Represents a pro-rata in-kind distribution of Common Stock of the Issuer by Partners IV without consideration to its members.
- F8Partners IV is the sole general partner of Ventures IV and Co-Investors IV. Dr. John Diekman, Andrew J. Schwab and Dr. Scott M. Rocklage, are the managing members of Partners IV, and have shared voting and investment power over the shares beneficially owned by Ventures IV and Co-Investors IV. Each of Partners IV, Dr. Diekman, Mr. Schwab, and Dr. Rocklage disclaims beneficial ownership of such shares except to the extent of its or their pecuniary interest therein.
- F9Represents the receipt of shares of Common Stock of the Issuer by virtue of the pro-rata in-kind distribution by Partners IV to the Schwab Family Trust, Andrew J. Schwab and Catarina N. Schwab, as Trustees of the Schwab Family Trust, dated October 26, 2007 ("Schwab Family Trust").